Lakefront Biotherapeutics GLPG Stock
Lakefront Biotherapeutics Price Chart
Lakefront Biotherapeutics GLPG Financial and Trading Overview
| Lakefront Biotherapeutics stock price | 27.73 USD |
| Previous Close | 0 USD |
| Open | 28.53 USD |
| Bid | 20.48 USD x 100 |
| Ask | 35.21 USD x 100 |
| Day's Range | 27.16 - 28.53 USD |
| 52 Week Range | 26.62 - 37.78 USD |
| Volume | 286.75K USD |
| Avg. Volume | 154.82K USD |
| Market Cap | 1.86B USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 3.1836967 |
| EPS (TTM) | 8.71 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 27.23 USD |
GLPG Valuation Measures
| Enterprise Value | -1092503680 USD |
| Trailing P/E | 3.1836967 |
| Forward P/E | -26.561838 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.7842623 |
| Price/Book (mrq) | 9.566138 |
| Enterprise Value/Revenue | -1.047 |
| Enterprise Value/EBITDA | -1.648 |
Trading Information
Lakefront Biotherapeutics Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -0.93% |
| S&P500 52-Week Change | 24.48% |
| 52 Week High | 37.78 USD |
| 52 Week Low | 26.62 USD |
| 50-Day Moving Average | 29.67 USD |
| 200-Day Moving Average | 32 USD |
GLPG Share Statistics
| Avg. Volume (3 month) | 154.82K USD |
| Avg. Daily Volume (10-Days) | 177.23K USD |
| Shares Outstanding | 65.9M |
| Float | 44.52M |
| Short Ratio | 6.95 |
| % Held by Insiders | 25.35% |
| % Held by Institutions | 22.30% |
| Shares Short | 1.37M |
| Short % of Float | 3.39% |
| Short % of Shares Outstanding | 2.08% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | NaN |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 46.82% |
| Operating Margin (ttm) | -982.91% |
| Gross Margin | 53.99% |
| EBITDA Margin | 63.51% |
Management Effectiveness
| Return on Assets (ttm) | 10.65% |
| Return on Equity (ttm) | 16.26% |
Income Statement
| Revenue (ttm) | 1.04B USD |
| Revenue Per Share (ttm) | 0.79 USD |
| Quarterly Revenue Growth (yoy) | -91.40% |
| Gross Profit (ttm) | 563.52M USD |
| EBITDA | 662.96M USD |
| Net Income Avi to Common (ttm) | 487.93M USD |
| Diluted EPS (ttm) | 8.71 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.98B USD |
| Total Cash Per Share (mrq) | 45.27 USD |
| Total Debt (mrq) | 6.44M USD |
| Total Debt/Equity (mrq) | 0.2 USD |
| Current Ratio (mrq) | 30.478 |
| Book Value Per Share (mrq) | 2.8987663 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -301599008 USD |
| Levered Free Cash Flow (ttm) | 210.97M USD |
Profile of Lakefront Biotherapeutics
| Country | United States |
| State | N/A |
| City | Mechelen |
| Address | Generaal De Wittelaan L11 A3 |
| ZIP | 2800 |
| Phone | 32 1 534 29 00 |
| Website | https://www.glpg.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that is in phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc. The company was incorporated in 1999 and is headquartered in Mechelen, Belgium.
Q&A For Lakefront Biotherapeutics Stock
What is a current GLPG stock price?
Lakefront Biotherapeutics GLPG stock price today per share is 27.73 USD.
How to purchase Lakefront Biotherapeutics stock?
You can buy GLPG shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Lakefront Biotherapeutics?
The stock symbol or ticker of Lakefront Biotherapeutics is GLPG.
Which industry does the Lakefront Biotherapeutics company belong to?
The Lakefront Biotherapeutics industry is Biotechnology.
How many shares does Lakefront Biotherapeutics have in circulation?
The max supply of Lakefront Biotherapeutics shares is 67.16M.
What is Lakefront Biotherapeutics Price to Earnings Ratio (PE Ratio)?
Lakefront Biotherapeutics PE Ratio is 3.18369670 now.
What was Lakefront Biotherapeutics earnings per share over the trailing 12 months (TTM)?
Lakefront Biotherapeutics EPS is 8.71 USD over the trailing 12 months.
Which sector does the Lakefront Biotherapeutics company belong to?
The Lakefront Biotherapeutics sector is Healthcare.
Lakefront Biotherapeutics GLPG included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25587.04 USD — |
-2.21
|
13.85B USD — | 25513.26 USD — | 25882.57 USD — | — - | 13.85B USD — |
|
US Tech Global Select Market Com
NQGS
US
|
12546.99 USD — |
-2.24
|
— — | 12513.27 USD — | 12692.24 USD — | — - | — — |
|
US Tech Biotechnology
NBI
US
|
6185.56 USD — |
+0.85
|
— — | 6121.03 USD — | 6233.73 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1184.66 USD — |
+0.75
|
— — | 1174.72 USD — | 1192.68 USD — | — - | — — |
|
US Tech Composite Total Return
XCMP
US
|
31560.2 USD — |
-2.21
|
— — | 31469.2 USD — | 31924.72 USD — | — - | — — |
|
Stlmt ID US Tech Biotechnology
NBX
US
|
3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}